Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Nat Immunol ; 22(10): 1280-1293, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-34556874

RESUMO

Traumatic brain injury (TBI) and cerebrovascular injury are leading causes of disability and mortality worldwide. Systemic infections often accompany these disorders and can worsen outcomes. Recovery after brain injury depends on innate immunity, but the effect of infections on this process is not well understood. Here, we demonstrate that systemically introduced microorganisms and microbial products interfered with meningeal vascular repair after TBI in a type I interferon (IFN-I)-dependent manner, with sequential infections promoting chronic disrepair. Mechanistically, we discovered that MDA5-dependent detection of an arenavirus encountered after TBI disrupted pro-angiogenic myeloid cell programming via induction of IFN-I signaling. Systemic viral infection similarly blocked restorative angiogenesis in the brain parenchyma after intracranial hemorrhage, leading to chronic IFN-I signaling, blood-brain barrier leakage and a failure to restore cognitive-motor function. Our findings reveal a common immunological mechanism by which systemic infections deviate reparative programming after central nervous system injury and offer a new therapeutic target to improve recovery.


Assuntos
Anti-Infecciosos/imunologia , Lesões Encefálicas Traumáticas/imunologia , Sistema Nervoso Central/imunologia , Imunidade Inata/imunologia , Animais , Barreira Hematoencefálica/imunologia , Encéfalo/imunologia , Modelos Animais de Doenças , Feminino , Interferon Tipo I/imunologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Transdução de Sinais/imunologia
2.
Nat Immunol ; 19(5): 442-452, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-29662169

RESUMO

Mild traumatic brain injury (mTBI) can cause meningeal vascular injury and cell death that spreads into the brain parenchyma and triggers local inflammation and recruitment of peripheral immune cells. The factors that dictate meningeal recovery after mTBI are unknown at present. Here we demonstrated that most patients who had experienced mTBI resolved meningeal vascular damage within 2-3 weeks, although injury persisted for months in a subset of patients. To understand the recovery process, we studied a mouse model of mTBI and found extensive meningeal remodeling that was temporally reliant on infiltrating myeloid cells with divergent functions. Inflammatory myelomonocytic cells scavenged dead cells in the lesion core, whereas wound-healing macrophages proliferated along the lesion perimeter and promoted angiogenesis through the clearance of fibrin and production of the matrix metalloproteinase MMP-2. Notably, a secondary injury experienced during the acute inflammatory phase aborted this repair program and enhanced inflammation, but a secondary injury experienced during the wound-healing phase did not. Our findings demonstrate that meningeal vasculature can undergo regeneration after mTBI that is dependent on distinct myeloid cell subsets.


Assuntos
Barreira Hematoencefálica/patologia , Concussão Encefálica/fisiopatologia , Meninges/patologia , Células Mieloides , Neovascularização Fisiológica/fisiologia , Animais , Feminino , Humanos , Masculino , Meninges/irrigação sanguínea , Camundongos
3.
PLoS Biol ; 16(10): e2005264, 2018 10.
Artigo em Inglês | MEDLINE | ID: mdl-30332405

RESUMO

Infiltrating monocyte-derived macrophages (MDMs) and resident microglia dominate central nervous system (CNS) injury sites. Differential roles for these cell populations after injury are beginning to be uncovered. Here, we show evidence that MDMs and microglia directly communicate with one another and differentially modulate each other's functions. Importantly, microglia-mediated phagocytosis and inflammation are suppressed by infiltrating macrophages. In the context of spinal cord injury (SCI), preventing such communication increases microglial activation and worsens functional recovery. We suggest that macrophages entering the CNS provide a regulatory mechanism that controls acute and long-term microglia-mediated inflammation, which may drive damage in a variety of CNS conditions.


Assuntos
Macrófagos/fisiologia , Microglia/fisiologia , Traumatismos da Medula Espinal/imunologia , Adulto , Animais , Sistema Nervoso Central/imunologia , Sistema Nervoso Central/lesões , Feminino , Voluntários Saudáveis , Humanos , Inflamação/imunologia , Contagem de Leucócitos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Microglia/imunologia , Monócitos , Fagocitose , Recuperação de Função Fisiológica
4.
PLoS Pathog ; 12(12): e1006022, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27907215

RESUMO

Cerebral malaria (CM) is a severe complication of Plasmodium falciparum infection that results in thousands of deaths each year, mostly in African children. The in vivo mechanisms underlying this fatal condition are not entirely understood. Using the animal model of experimental cerebral malaria (ECM), we sought mechanistic insights into the pathogenesis of CM. Fatal disease was associated with alterations in tight junction proteins, vascular breakdown in the meninges / parenchyma, edema, and ultimately neuronal cell death in the brainstem, which is consistent with cerebral herniation as a cause of death. At the peak of ECM, we revealed using intravital two-photon microscopy that myelomonocytic cells and parasite-specific CD8+ T cells associated primarily with the luminal surface of CNS blood vessels. Myelomonocytic cells participated in the removal of parasitized red blood cells (pRBCs) from cerebral blood vessels, but were not required for the disease. Interestingly, the majority of disease-inducing parasite-specific CD8+ T cells interacted with the lumen of brain vascular endothelial cells (ECs), where they were observed surveying, dividing, and arresting in a cognate peptide-MHC I dependent manner. These activities were critically dependent on IFN-γ, which was responsible for activating cerebrovascular ECs to upregulate adhesion and antigen-presenting molecules. Importantly, parasite-specific CD8+ T cell interactions with cerebral vessels were impaired in chimeric mice rendered unable to present EC antigens on MHC I, and these mice were in turn resistant to fatal brainstem pathology. Moreover, anti-adhesion molecule (LFA-1 / VLA-4) therapy prevented fatal disease by rapidly displacing luminal CD8+ T cells from cerebrovascular ECs without affecting extravascular T cells. These in vivo data demonstrate that parasite-specific CD8+ T cell-induced fatal vascular breakdown and subsequent neuronal death during ECM is associated with luminal, antigen-dependent interactions with cerebrovasculature.


Assuntos
Vasos Sanguíneos/patologia , Barreira Hematoencefálica/patologia , Tronco Encefálico/patologia , Linfócitos T CD8-Positivos/patologia , Malária Cerebral/patologia , Animais , Modelos Animais de Doenças , Citometria de Fluxo , Imuno-Histoquímica , Malária Cerebral/imunologia , Camundongos , Camundongos Transgênicos , Plasmodium berghei
5.
Trends Immunol ; 36(10): 637-650, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26431941

RESUMO

The central nervous system (CNS) contains a sophisticated neural network that must be constantly surveyed in order to detect and mitigate a diverse array of challenges. The innate and adaptive immune systems actively participate in this surveillance, which is critical for the maintenance of CNS homeostasis and can facilitate the resolution of infections, degeneration, and tissue damage. Infections and sterile injuries represent two common challenges imposed on the CNS that require a prompt immune response. While the inducers of these two challenges differ in origin, the resultant responses orchestrated by the CNS share some overlapping features. Here, we review how the CNS immunologically discriminates between pathogens and sterile injuries, mobilizes an immune reaction, and, ultimately, regulates local and peripherally-derived immune cells to provide a supportive milieu for tissue repair.


Assuntos
Infecções do Sistema Nervoso Central/imunologia , Sistema Nervoso Central/imunologia , Vigilância Imunológica , Traumatismos do Sistema Nervoso/imunologia , Animais , Sistema Nervoso Central/citologia , Sistema Nervoso Central/metabolismo , Infecções do Sistema Nervoso Central/genética , Infecções do Sistema Nervoso Central/metabolismo , Quimiotaxia de Leucócito , Interações Hospedeiro-Patógeno/imunologia , Humanos , Sistema Imunitário/citologia , Sistema Imunitário/fisiologia , Neuroimunomodulação , Receptores de Reconhecimento de Padrão/genética , Receptores de Reconhecimento de Padrão/metabolismo , Traumatismos do Sistema Nervoso/genética , Traumatismos do Sistema Nervoso/metabolismo , Cicatrização
6.
Science ; 353(6301): 783-5, 2016 Aug 19.
Artigo em Inglês | MEDLINE | ID: mdl-27540166

RESUMO

Traumatic brain injury (TBI) elicits an inflammatory response in the central nervous system (CNS) that involves both resident and peripheral immune cells. Neuroinflammation can persist for years following a single TBI and may contribute to neurodegeneration. However, administration of anti-inflammatory drugs shortly after injury was not effective in the treatment of TBI patients. Some components of the neuroinflammatory response seem to play a beneficial role in the acute phase of TBI. Indeed, following CNS injury, early inflammation can set the stage for proper tissue regeneration and recovery, which can, perhaps, explain why general immunosuppression in TBI patients is disadvantageous. Here, we discuss some positive attributes of neuroinflammation and propose that inflammation be therapeutically guided in TBI patients rather than globally suppressed.


Assuntos
Lesões Encefálicas/patologia , Lesões Encefálicas/terapia , Inflamação/patologia , Neuroproteção , Animais , Lesões Encefálicas/complicações , Modelos Animais de Doenças , Humanos , Inflamação/etiologia , Células Mieloides/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA